Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Queensland Health
Teva
Fish and Richardson
Healthtrust
Covington
Citi
Cipla
Mallinckrodt

Generated: August 14, 2018

DrugPatentWatch Database Preview

Sciegen Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?

SCIEGEN PHARMS INC has twenty-seven approved drugs.

There is one tentative approval on SCIEGEN PHARMS INC drugs.

Summary for Sciegen Pharms Inc
US Patents:0
Tradenames:24
Ingredients:23
NDAs:27

Drugs and US Patents for Sciegen Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc IRBESARTAN irbesartan TABLET;ORAL 204774-003 Dec 7, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Sciegen Pharms Inc DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 203907-001 Oct 29, 2014 AB RX No No ➤ Sign Up ➤ Sign Up
Sciegen Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 205236-004 May 26, 2017 AA RX No No ➤ Sign Up ➤ Sign Up
Sciegen Pharms Inc ARIPIPRAZOLE aripiprazole TABLET, ORALLY DISINTEGRATING;ORAL 207240-002 Apr 18, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Sciegen Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 205236-001 May 26, 2017 AA RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Accenture
UBS
Queensland Health
Express Scripts
Moodys
Daiichi Sankyo
Healthtrust
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.